Rafael Holdings, Inc. Class B Common Stock Profile
About
Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.
Rafael Holdings, Inc. Class B Common Stock Statistics
Valuation Measures
Market Capitalization2
49.97M
Enterprise Value
44.19M
Enterprise Value/EBITDA(ttm)
-0.43
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
72.49
Price to Book(mrq)
0.64
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
75.99%
Operating Margin(ttm)
-6867.00%
Profit Margin(ttm)
-2619.86%
Return on Equity(ttm)
-53.71%
Return on Invested Capital(ttm)
-80.47%
Return on Assets(ttm)
-48.78%
Income Statement
Revenue(ttm)
697.00K
Revenue Per Share(ttm)
0.03
Gross Profit(ttm)
506.00K
EBITDA(ttm)3
-103.70M
Net Income Available to Common(ttm)
-39.78M
Diluted EPS(ttm)
-1.67
Share Statistics
Beta (5Y Monthly)
1.12
52-Week Change
18.42%
S&P 500 52-Week Change
18.45%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
24.67M
Dividend Yield
0.00%
Float4
22.16M
% Held by Insiders
10.20%
% Held by Institutions
11.30%
Balance Sheet
Total Cash(mrq)
54.30M
Total Cash Per Share(mrq)
2.20
Total Debt(mrq)
2.39M
Total Debt/Equity(mrq)
3.09%
Current Ratio(mrq)
9.74%
Quick Ratio(mrq)
9.74%
Book Value Per Share(mrq)
3.15
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.13
Free Cash Flow(ytd)
-3.05M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.